Absorbed Dose to Very Low Birth Weight Infants from 18F-fluorodeoxyglucose
Overview
Nuclear Medicine
Affiliations
The radiation absorbed dose to very low birth weight infants from 18F-fluorodeoxyglucose was investigated. Ten newborns undergoing clinical positron tomography lung imaging were included in this study. Two consecutive 45-min dynamic scans immediately following intravenous injection of fluorodeoxyglucose were acquired; the first was over the head, and the second was over the chest. Time-activity curves were generated for the brain, heart wall, lungs, and, when visible, the kidneys. The cumulated activity measurements obtained were for the entire organ masses; these masses were much smaller than the corresponding organ masses for the newborn mathematical model. Patient-specific dosimetry yielded average doses of 2.5 x 10(-1) mGy MBq(-1) for the brain, 6.8 x 10(-1) mGy MBq(-1) for the heart wall, 2.2 x 10(-1) mGy MBq(-1) for the kidneys, and 4.4 x 10(-1) mGy MBq(-1) for the lungs. The effective dose was estimated to be 2.1 x 10(-1) mSv MBq(-1), which is half that previously published for newborns but still an order of magnitude higher than that for adults.
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric F-FDG PET/CT for Oncology 1.0.
Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M J Nucl Med. 2020; 62(1):99-110.
PMID: 33334912 PMC: 8679588. DOI: 10.2967/jnumed.120.254110.
Khamwan K, Plyku D, OReilly S, Goodkind A, Cao X, Fahey F EJNMMI Res. 2016; 6(1):28.
PMID: 26988861 PMC: 4797375. DOI: 10.1186/s13550-016-0179-6.
Eberlein U, Broer J, Vandevoorde C, Santos P, Bardies M, Bacher K Eur J Nucl Med Mol Imaging. 2011; 38(12):2269-81.
PMID: 21877166 PMC: 3218267. DOI: 10.1007/s00259-011-1904-z.